Medical cannabis

Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries

Retrieved on: 
Monday, February 6, 2023
Research, Medical cannabis, Neuron, Excitotoxicity, Parkinson's disease, OTC, Glutamic acid, Cannabidiol, Central nervous system, Brain damage, Cerebral cortex, Patient, SAN, El Siglo, Medical Marijuana, Inc., THC, Mortality, Death, Pharmaceutical industry, Vaccine, CBD

SAN DIEGO, CA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –  Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® recently took part in a collaboration on a study to demonstrate the effectiveness of hemp-based cannabidiol (CBD) in the treatment of Parkinson's Disease.  The Company is also collaborating with the Center for Research and Advanced Studies of Neurological Diseases at the Siglo XXI National Medical Center, on a preclinical study in an animal model that demonstrated the ability to decrease extracellular glutamate levels that can lead to traumatic brain injuries.

Key Points: 
  • The Company is also collaborating with the Center for Research and Advanced Studies of Neurological Diseases at the Siglo XXI National Medical Center, on a preclinical study in an animal model that demonstrated the ability to decrease extracellular glutamate levels that can lead to traumatic brain injuries.
  • In this study, it was also shown that the application of CBD helps sensorimotor improvement,” Dr. Rocha stated.
  • Dr. Rocha added: “The results obtained in this study help to understand how the oral application of cannabidiol reduces excitotoxicity caused by long-term traumatic brain injuries and facilitates functional recovery.
  • HempMeds' commitment is to free access around the globe enabling people worldwide everyday to obtain the health benefits of cannabis-based products in an easy way.

Organic Remedies Launches New Medical Marijuana Brand Product Line Through Exclusive Partnership With Former Steelers Linebacker Ryan Shazier

Retrieved on: 
Friday, January 27, 2023
Pittsburgh Steelers, Life, Timeline of cannabis laws in the United States, Medical cannabis, Quality of life, Ryan Shazier, Injury, Cincinnati Bengals, Capsule, Sale, Depression, Patient, Rehabilitation, Anxiety, Steel City, NFL, Pain, 2008 Cincinnati Bengals season, Pharmaceutical industry

CARLISLE, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Organic Remedies, a medical marijuana cultivation and research organization based in south central Pennsylvania, has announced the official launch of its Steel City Greats Ryan Shazier brand product line.

Key Points: 
  • CARLISLE, Pa., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Organic Remedies, a medical marijuana cultivation and research organization based in south central Pennsylvania, has announced the official launch of its Steel City Greats Ryan Shazier brand product line.
  • Partnering with former Steelers linebacker and NFL Pro Bowler Ryan Shazier, Organic Remedies introduced the product line to help patients improve their quality of life by managing pain, anxiety, and depression.
  • What many may not know is that Shazier benefitted from the use of medical marijuana as he worked to regain his mobility following his injury.
  • Shazier said his unique brand of medical marijuana products will help others succeed in achieving their wellness goals.

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point

Retrieved on: 
Tuesday, January 24, 2023
Health, Medical cannabis, Family, Patient, Child, Cannabis, ANVISA, OTC, Epilepsy, CDKL5, Pharmacy, Alessandra Patelli, Medical Marijuana, Inc., Growth, CBD, News, Coffee, Drug

SAN DIEGO, CA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary HempMeds® Brasil launched two new full spectrum products in Brazil. The two products represent the most competitively priced products available in the region, creating greater market opportunity for the subsidiary.

Key Points: 
  • The two products represent the most competitively priced products available in the region, creating greater market opportunity for the subsidiary.
  • Since then HempMeds Brasil has experienced consistent growth in reaching new patients through its relationships with various medical associations as well as its direct-to-consumer business.
  • CBD products sold in Brazil require a prescription from a doctor and once obtained HempMeds Brazil assists Patients to obtain the prescribed product.
  • We remain committed to being a cannabis industry leader, and to driving positive global change as we do so.”
    To learn more about HempMeds® Brasil, please visit www.hempmeds.com.br .

Agrify Announces Strategic Plan to Foster Sustainable Long-Term Growth

Retrieved on: 
Monday, January 23, 2023
Friction, RDP, University, Ecosystem, Classification, Cannabis, TTK, Human resources, Government, Medical cannabis, Ethanol, 2010 Burkinabé presidential election, Growth, Organization, Customer experience, Research, Fine chemical, Marketing, Pharmaceutical industry, Drug, Management

Agrify has reduced its manufacturing and production costs through more effective supplier agreements, volume discounts driven by increased purchasing power, and less of a reliance on contract manufacturers.

Key Points: 
  • Agrify has reduced its manufacturing and production costs through more effective supplier agreements, volume discounts driven by increased purchasing power, and less of a reliance on contract manufacturers.
  • Agrify has also been able to simplify its organizational structure and embark on a strategic consolidation of its offices and facilities.
  • Agrify believes that these improvements could result in up to $7 million in cost savings during 2023, and the Company anticipates that it may be able to accrue more savings as the year progresses.
  • The Company expects to have several more customer cultivation facilities coming online in 2023, including some highly anticipated Agrify TTK Solution customer sites.

Verano Announces the Opening of MÜV Navarre, the Company’s 63rd Florida Location

Retrieved on: 
Thursday, January 19, 2023
Medical cannabis, Google Play, Capsule, CSE, 121st, Patient, Apple, Hospital

MÜV Navarre, located at 6863 Navarre Parkway, is open Monday through Saturday from 9 a.m. to 5 p.m. and Sunday from 11 a.m. to 5 p.m., local time.

Key Points: 
  • MÜV Navarre, located at 6863 Navarre Parkway, is open Monday through Saturday from 9 a.m. to 5 p.m. and Sunday from 11 a.m. to 5 p.m., local time.
  • According to Florida’s Office of Medical Marijuana Use, there are currently over 783,000 qualified medical cannabis patients in the state.
  • Florida medical cannabis sales are projected to potentially reach $2.5 billion by 2026, as reported by MJBiz Factbook 2022 .
  • For more information about MÜV Navarre medical cannabis dispensary, visit muvfl.com .

GRN Holdings Corporation Signs Letter of Intent for Corporate Restructuring

Retrieved on: 
Tuesday, January 17, 2023
Medical cannabis, Medical Marijuana, Inc., OTC Markets Group, Seed, LOI, KonoSuba: God's Blessing on this Wonderful World! Legend of Crimson, Growth, Farmer, Security (finance), Drug, Cannabis

ESTERO, Fla., Jan. 17, 2023 (GLOBE NEWSWIRE) -- GRN Holding Corporation, Inc. (OTC Pink: GRNF) is pleased to announce it has entered into a non-binding letter of intent for a corporate restructuring with Marijuana Inc. of Florida.

Key Points: 
  • ESTERO, Fla., Jan. 17, 2023 (GLOBE NEWSWIRE) -- GRN Holding Corporation, Inc. (OTC Pink: GRNF) is pleased to announce it has entered into a non-binding letter of intent for a corporate restructuring with Marijuana Inc. of Florida.
  • The Company expects to announce additional details regarding the proposed business consolidation when a definitive agreement is executed, which is expected in early 2023.
  • Any transaction would be subject to board and equity holder approval of both companies, regulatory approvals, and other customary conditions.
  • One World Legends has also brought “Landrace Strains” to the company enabling the growth and distribution of “Acapulco Gold”, “Panama Red”, and many others.”

Verano Announces the Opening of MÜV Lake City, the Company’s 62nd Florida Location and 120th Retail Location Nationwide

Retrieved on: 
Wednesday, December 21, 2022
Google Play, Apple, City, Patient, CSE, Capsule, Medical cannabis, Drug, Hospital

MÜV Lake City, located at 2938 W US Highway 90, is open Monday through Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m., local time.

Key Points: 
  • MÜV Lake City, located at 2938 W US Highway 90, is open Monday through Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m., local time.
  • According to Florida’s Office of Medical Marijuana Use, there are currently over 776,000 qualified medical cannabis patients in the state.
  • Florida medical cannabis sales are projected to potentially reach $2.5 billion by 2026, as reported by MJBiz Factbook 2022 .
  • “Opening MÜV Lake City, our first medical cannabis dispensary in Columbia County, adds another convenient location for our valued patients across northern Florida,” said John Tipton, President of Verano.

Simplifya Expands Operations to 28 States; Launches Suite of RegTech Solutions to Keep Minnesota’s Cannabis Ecosystem Compliant

Retrieved on: 
Wednesday, December 14, 2022
Midterm election, SOP, Checklist, Lawyer, Documentation, Democrat, Sale, Running, Medical cannabis, Headache, Control, Senate, Cannabis, Burden, Regulatory technology, Patient, Audit, Drug, Medical device

DENVER, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Simplifya (“Simplifya” or “the Company”), the leading regulatory and operational compliance software platform serving the cannabis industry, announced it has expanded the Company’s operational footprint to 28 states with the launch of its core suite of cannabis compliance solutions in Minnesota. The Company’s suite of RegTech solutions include Simplifya Standard Operating Procedures (“SOPs”), Simplifya Smart Cabinet (“Smart Cabinet”) and Simplifya Self Audit (“Self Audit”), which have been specifically designed to help cannabis and ancillary businesses stay abreast of regulatory changes, cost-effectively manage risks and remain legally compliant under Minnesota’s laws.

Key Points: 
  • The Company’s suite of RegTech solutions include Simplifya Standard Operating Procedures (“SOPs”) , Simplifya Smart Cabinet (“Smart Cabinet”) and Simplifya Self Audit (“Self Audit”), which have been specifically designed to help cannabis and ancillary businesses stay abreast of regulatory changes, cost-effectively manage risks and remain legally compliant under Minnesota’s laws.
  • Tim Walz is making adult-use cannabis legalization a priority for the upcoming legislative session.
  • “For in-market businesses and those looking to operate within Minnesota’s cannabis ecosystem, it’s critical to be proactive about compliance.
  • Simplifya is the cannabis industry’s leading regulatory and operational compliance software platform; our suite of products takes the guesswork out of confusing and continually changing state and local regulations.

IGC Applauds Signing of Bipartisan Medical Marijuana and Cannabidiol Research Expansion Act

Retrieved on: 
Wednesday, December 7, 2022
Medical cannabis, Woman, Annual report, NYSE, Failure, IGC, Dysmenorrhea, Chronic pain, FDA, THC, Pain, Agitation, Legislation, Seizure, Cannabis, Premenstrual syndrome, Drug development, Risk, Dementia, Efficacy, IP, PMS, CBD, Research, Disease, Safety, COVID-19, Drug, Pharmaceutical industry

POTOMAC, Md., Dec. 07, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc (NYSE American: IGC) (“IGC” or the “Company”), applauds the signing of the Medical Marijuana and Cannabidiol Research Expansion Act (“the Act”), which was signed into law by President Biden on Friday Dec. 2, 2022.

Key Points: 
  • POTOMAC, Md., Dec. 07, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- India Globalization Capital, Inc (NYSE American: IGC) (“IGC” or the “Company”), applauds the signing of the Medical Marijuana and Cannabidiol Research Expansion Act (“the Act”), which was signed into law by President Biden on Friday Dec. 2, 2022.
  • The law provides legislation establishing a new registration process for conducting research on marijuana and for manufacturing marijuana products for research purposes and drug development.
  • “The study and development of cannabis for its potential therapeutic benefits is at the center of our work at IGC-Pharma,” commented Ram Mukunda, CEO of IGC.
  • “For many years, onerous federal barriers have made it difficult to efficiently source and study cannabis for pharmaceutical applications.

Ayr Wellness Kicks Off “12 Days of Giving,” a $100,000 Holiday Donation Campaign Dedicated to Restorative Justice Initiatives

Retrieved on: 
Monday, December 5, 2022
Slate, Medical cannabis, OTCQX, Public policy, Medicine, Financial management, Freedom, Ecosystem, News, Corporate social responsibility, CSE, Cannabis, Research, War, COVID-19, Partnership, Drug

The campaign will run through December 16th, 2022, and proceeds will benefit those negatively impacted by cannabis prohibition.

Key Points: 
  • The campaign will run through December 16th, 2022, and proceeds will benefit those negatively impacted by cannabis prohibition.
  • “Ayr’s ‘12 Days of Giving’ initiative aims to reinforce our commitment to being a Force for Good by activating twelve days of charitable giving across our retail footprint,” said David Goubert, President of Ayr.
  • “This marks Ayr’s second year of the program, which is poised to directly benefit the families of those who have been incarcerated for cannabis offenses.
  • To learn more about or donate to Ayr’s 12 Days of Giving Campaign, visit https://ayrwellness.com/12-days .